Median overall survival of patients with stage IV NSCLC.

Figshare2018-08-27 更新2026-04-29 收录

晚期肺癌生存预后

肿瘤临床结局

数据链接：

https://figshare.com/articles/dataset/Median_overall_survival_of_patients_with_stage_IV_NSCLC_/7014584 数据链接链接失效反馈

官方服务：

资源简介：

Median overall survival of patients with stage IV NSCLC.

创建时间：

2018-08-27

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer

结直肠癌辅助化疗

肿瘤临床结局

Background There are robust data supporting the contribution of oxaliplatin (L-OHP) regarding clinical outcomes for colorectal cancer (CRC) in an adjuvant setting in European and US trials; however, t

NIAID Data Ecosystem50

The retrospective study as the 1st-line chemotherapy of fluorouracil and bevacizumab for the frail-patients with unresectable or metastatic colorectal cancer

化疗疗效

肿瘤临床结局

Primary outcome(s): PFS, OS, RR, DCR, Adverse event

NIAID Data Ecosystem30

Five-year survival rates for 481 nasopharyngeal carcinoma patients with retropharyngeal lymph nodes metastasis according to the characteristics of retropharyngeal lymph node metastasis.

鼻咽癌预后

肿瘤临床结局

Abbreviations: DFS = disease-free survival; DMFS = Distant metastasis-free survival; LRRFS = Locoregional relapse-free survival. *P values were calculated by the unadjusted log-rank test. Five-y

NIAID Data Ecosystem20

Supplementary Material for: Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort

晚期肝细胞癌序贯治疗

肿瘤临床结局

Introduction: The number of efficacious systemic agents for advanced hepatocellular carcinoma (HCC) has rapidly increased over the past 3 years. However, guidance for optimal sequential systemic treat

NIAID Data Ecosystem40

Characteristics and outcomes of patients with pneumonitis during systemic anti-cancer therapy (N = 44)

抗癌治疗相关肺炎

肿瘤临床结局

Characteristics and outcomes of patients with pneumonitis during systemic anti-cancer therapy (N = 44)

NIAID Data Ecosystem20